Hyperglycemia induces an immunosuppressive microenvironment in colorectal cancer liver metastases by recruiting peripheral blood monocytes through the CCL3-CCR1 axis
Journal for ImmunoTherapy of Cancer · 2025
DOI: 10.1136/jitc-2024-011310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2025. Verfasst von Han Peng und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Southwest Cancer Centre, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, Receptors, CCR1, Tumor Microenvironment. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Nature Science Foundation of China, Nature Science Foundation of Chongqing, Nature Science Foundation of Chengdu.
Abstract (Originalsprache)
Background
The treatment of colorectal cancer liver metastasis (CRLM), a leading cause of mortality in patients with colorectal cancer, is complicated by type 2 diabetes (T2D). This study aimed to investigate the CRLM immune microenvironment in the context of T2D and identify potential therapeutic targets.
Methods
A hyperglycemic CRLM mouse model was established. Seven single-cell RNA sequencing datasets were analyzed, including three peripheral blood mononuclear cells (PBMCs) datasets (from healthy donors and T2D patients) and four datasets with 20 CRLM samples and matching PBMCs datasets, to explore the immune characteristics and remodeling of the tumor microenvironment in CRLM with concurrent T2D.
Results
CD8 + T cells exhibited dysfunction and exhaustion in liver metastasis from patients with CRLM and T2D; the proportions of various CD4 + T cell subpopulations were also altered, and the number of myeloid cells and their function was increased. Myeloid cells in CRLM from patients with T2D exhibited high expression levels of CCL3, which recruited peripheral blood monocytes expressing high levels of CCR1, leading to an accumulation of myeloid cells and an immunosuppressive tumor microenvironment. Recruited cells exhibited enhanced T cell communication abilities, indicating an augmented immunosuppressive capacity. In addition, CCR1 expression in peripheral blood monocytes from patients with CRLM was closely correlated with the immunosuppressive tumor microenvironment, suggesting that CCR1 expression levels may predict immune cell phenotype and prognosis in patients with CRLM and T2D.
Conclusions
Our study revealed complex changes in the tumor microenvironment of patients with CRLM and T2D. In particular, a novel mechanism was identified by which hyperglycemia regulates immunosuppression: the CCL3–CCR1 signaling axis. This finding offers a novel potential therapeutic target for patients with CRLM and T2D and provides an important theoretical basis for the future prediction of the prognosis of these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology and Southwest Cancer Centre, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
- Department of Gastroenterology, School of Medicine, Chongqing University Cancer Hospital, Chongqing University, Chongqing, China.
- Endocrinology/Osteoporosis, West China School of Public Health and West China Forth Hospital, Sichuan University, Chengdu, China.
- Department of Respiratory Medicine, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
- Department of Hematology, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
- Department of Oncology and Southwest Cancer Centre, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China huangshuo317@tmmu.edu.cn lianghoujie@sina.com.
Förderung
- National Nature Science Foundation of China
- Nature Science Foundation of Chongqing
- Nature Science Foundation of Chengdu
Zitieren
APA
Peng, H., Pan, Y., Sun, Y., Wang, X., Fan, X., Wang, Y., Zhao, L., Li, X., Dong, Y., Chen, J., Zhou, J., Du, Y., Yu, Q., Yang, Y., Zhang, Y., Li, J., Liang, H., & Huang, S. (2025). Hyperglycemia induces an immunosuppressive microenvironment in colorectal cancer liver metastases by recruiting peripheral blood monocytes through the CCL3-CCR1 axis. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2024-011310
Vancouver
Peng H, Pan Y, Sun Y, Wang X, Fan X, Wang Y, et al. Hyperglycemia induces an immunosuppressive microenvironment in colorectal cancer liver metastases by recruiting peripheral blood monocytes through the CCL3-CCR1 axis. Journal for ImmunoTherapy of Cancer. 2025. doi:10.1136/jitc-2024-011310
BibTeX
@article{Peng2025,
author = {Peng, Han and Pan, Yuwei and Sun, Yixin and Wang, Xuesong and Fan, Xue and Wang, Yajuan and Zhao, Lintao and Li, Xi and Dong, Yan and Chen, Jianfang and Zhou, Jie and Du, Yun and Yu, Qing and Yang, Yongtao and Zhang, Yue and Li, Jianjun and Liang, Houjie and Huang, Shuo},
title = {Hyperglycemia induces an immunosuppressive microenvironment in colorectal cancer liver metastases by recruiting peripheral blood monocytes through the CCL3-CCR1 axis},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2025},
doi = {10.1136/jitc-2024-011310}
}
EUVIMED